BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17043436)

  • 21. Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.
    Kang MJ; Kim MS; Choi EH; Lee KE; Kim YK; Choi HJ
    Korean J Intern Med; 2007 Mar; 22(1):63-6. PubMed ID: 17427651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA; Khadir M; Dinparasti-Saleh R
    Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
    Mor A; Bingham CO; Barisoni L; Lydon E; Belmont HM
    J Rheumatol; 2005 Apr; 32(4):740-3. PubMed ID: 15801034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of leprosy in a patient with rheumatoid arthritis during treatment with etanercept: a case report.
    Lluch P; Urruticoechea A; Lluch J; Moll MC; Matos M; Benet JM; Ene L; Cañete JD
    Semin Arthritis Rheum; 2012 Oct; 42(2):127-30. PubMed ID: 22542278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
    Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
    Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
    Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of tuberculous arthritis following the use of etanercept.
    Choi SW; Ahn JJ; Hwang YT; Koh SH; Cho SD
    Korean J Intern Med; 2009 Dec; 24(4):397-401. PubMed ID: 19949742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
    Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
    Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etanercept].
    Takeuchi T; Amano K
    Nihon Rinsho; 2002 Dec; 60(12):2390-6. PubMed ID: 12510367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
    Sakaida H; Komase Y; Takemura T
    Mod Rheumatol; 2010 Dec; 20(6):611-6. PubMed ID: 20585825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of pulmonary nontuberculous mycobacteriosis aggravated during treatment with etanercept for rheumatoid arthritis].
    Esaki T; Sugimoto M; Mori S; Yamashita A; Matsumoto M; Kohrogi H
    Nihon Kokyuki Gakkai Zasshi; 2010 Apr; 48(4):312-6. PubMed ID: 20432974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept.
    Hu S; Cohen D; Murphy G; Mody E; Qureshi AA
    Cutis; 2008 Apr; 81(4):336-8. PubMed ID: 18491481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
    Stokes MB; Foster K; Markowitz GS; Ebrahimi F; Hines W; Kaufman D; Moore B; Wolde D; D'Agati VD
    Nephrol Dial Transplant; 2005 Jul; 20(7):1400-6. PubMed ID: 15840673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
    Ferraccioli GF; Assaloni R; Perin A
    Lancet; 2002 Aug; 360(9333):645; author reply 646. PubMed ID: 12241963
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.
    Exarchou SA; Voulgari PV; Markatseli TE; Zioga A; Drosos AA
    Scand J Rheumatol; 2009; 38(5):328-31. PubMed ID: 19579151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute ocular myositis occurring under etanercept for rheumatoid arthritis.
    Couderc M; Mathieu S; Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2014 Oct; 81(5):445-6. PubMed ID: 24746476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.